Verax Biomedical, Incorporated
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Verax Biomedical, Incorporated
While a panel of US FDA experts agreed that pathogen reduction technology is a promising strategy for reducing blood platelet contaminations, they raised concerns about the cost of implementing the technology. The maker of the technology, Cerus, says the panel was under-briefed and distracted.
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
- In Vitro Diagnostics
- Infection Control-Sterilization
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
Drug Discovery Tools
- Drug Discovery Tools
- Other Names / Subsidiaries
- Verax Biomedical Inc.
- Verax Biomedical, Inc.